Flagship Ventures Fund V General Partner LLC — SEC Form 4 filings

SEC reporting owner CIK 1724575. 1 Form 4 filing on record with FilingPulse; latest filed 2026-01-15.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2026-01-15 to 2026-01-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Foghorn Therapeutics Inc. (FHTX)Director, 10% owner13

Form 4 filings — Flagship Ventures Fund V General Partner LLC

FiledFormIssuerReported transactionsSource
2026-01-154Foghorn Therapeutics Inc. (FHTX)
jointly with Flagship Pioneering, LLC, Flagship Pioneering Fund VII General Partner LLC, Flagship Pioneering Fund VII, L.P., Flagship Pioneering Special Opportunities Fund II General Partner LLC, Flagship Pioneering Special Opportunities Fund II, L.P., Flagship Ventures Fund V, L.P., Flagship Ventures Opportunities Fund I General Partner LLC, Flagship Ventures Opportunities Fund I, L.P., AFEYAN NOUBAR
Grant/award (A): 2,235,468 (derivative) @ $6.71 · Grant/award (A): 1,117,734 (derivative) · Grant/award (A): 1,117,734 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →